Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Argus Health
Boehringer Ingelheim
Cerilliant
Johnson and Johnson
QuintilesIMS
Medtronic
US Army
Cantor Fitzgerald

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020527

« Back to Dashboard

NDA 020527 describes PREMPRO, which is a drug marketed by Wyeth Pharms Inc and is included in two NDAs. It is available from four suppliers. Additional details are available on the PREMPRO profile page.

The generic ingredient in PREMPRO is estrogens, conjugated; medroxyprogesterone acetate. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the estrogens, conjugated; medroxyprogesterone acetate profile page.
Summary for 020527
Tradename:PREMPRO
Applicant:Wyeth Pharms Inc
Ingredient:estrogens, conjugated; medroxyprogesterone acetate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020527
Suppliers and Packaging for NDA: 020527
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PREMPHASE 14/14 estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527 NDA Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. 0046-1105 N 0046-1105-11
PREMPHASE 14/14 estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527 NDA Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. 0046-1106 N 0046-1106-11

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.625MG;2.5MG
Approval Date:Nov 17, 1995TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.625MG,0.625MG;N/A,5MG
Approval Date:Nov 17, 1995TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.625MG;5MG
Approval Date:Jan 9, 1998TE:RLD:Yes

Expired US Patents for NDA 020527

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc PREMPRO estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-004 Mar 12, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Pharms Inc PREMPHASE 14/14 estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-002 Nov 17, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Pharms Inc PREMPHASE 14/14 estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-002 Nov 17, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Pharms Inc PREMPRO estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-003 Jan 9, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
QuintilesIMS
Mallinckrodt
McKinsey
AstraZeneca
US Department of Justice
Express Scripts
Accenture
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.